Role of human papilloma virus in oral tongue squamous cell carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 4, 2011, Pages 889-896

  Elango, Kalavathy Jayapal ^a   Suresh, Amritha ^a   Erode, Elango Murugaian ^a   Subhadradevi, Lakshmi ^b   Ravindran, Hiran Kattilaparambil ^c   Iyer, Subramania Kulathu ^c   Iyer, Sundaram Karimassery Rama ^c   Kuriakose, Moni Abraham ^a  

^a Multispecialty Hospital Shaw Mazumdar Medical Centre   (India)

^b REGIONAL CANCER CENTRE   (India)

^c AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Carcinogenesis; HPV; IHC; PCR; Tongue SCC

Indexed keywords

EID: 84856245713     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Balaram P, Nalinakumari, KR, Abraham E, et al (1995). Human papillomavirus in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer, 61, 450-4.
2. Balz V, Scheckenbach K, Gotte K, et al (2003). Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res, 63, 1188-91.
3. Conrad M, Goldstein D, Andresson T, Schlegel R (1994). The E5 protein of HPV 6, but not HPV 16, associates efficiently with cellular growth factor receptors. Virology, 200, 796-800.
4. Crusius K, Auvinen E, Steuer B, Gaissert H, Alonso A (1998). The human papillomavirus type 16 E5 protein modulates ligand-dependent activation of the EGF-receptor family in the human epithelial cell line HaCaT. Exp Cell Res, 241, 76-83.
5. Cullen AP, Reid R, Campion M, Lörincz AT (1991). Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol, 65, 606-12.
6. El-Mofty SK, Lu DW (2003). Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: A distinct clinicopathologic and molecular disease entity. Am J Surg Pathol, 27, 1463-70.
7. Elango JK, Gangadharan P, Sumithra S, Kuriakose MA, (2006). Trends of head and neck cancer in urban and rural population. Asian Pac J Cancer Prev, 7, 108-12.
8. Fakhry C, Westra WH, Li S, et al (2008). Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst, 100, 261-9.
9. Gallo G, Bibbo M, Bagella L, et al (2003). Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol, 56, 532-6.
10. Gillison ML (2004). Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol, 31, 744-54
11. Gillison ML, Koch WM, Capone RB, et al (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst, 92, 709-20.
12. Gillison ML, Shah KV (2001). Human papillomavirus-associated head and neck squamous cell carcinoma:mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol, 13, 183-8.
13. Hammarstedt L, Lindquist D, Dahlstrand H, et al (2006). Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer, 119, 2620-3.
14. Haraf DJ, Nodzenski E, Brachman D, et al (1996). Human papilloma virus and p53 in head and neck cancer: Clinical correlates and survival. Clin Cancer Res, 2, 755-762.
15. Hönig JF (1992). Non radioactive in situ hybridization for detection of human papilloma virus DNA in squamous cell carcinoma of tongue. Bull Group Int Rech Sci Stomatol Odontol, 35, 107-15.
16. Hormia M, Willberg J, Ruokonen H, Syrjänen S (2005). Marginal periodontium as a potential reservoir of human papillomavirus in oral mucosa. J Periodontol, 76, 358-63.
17. Hwang ES, Nottoli T, Dimaio D, (1995). The HPV 16 E5 protein:expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology, 211, 227-33.
18. Jeon S, Allen-Hoffmann BL, Lambert PF (1995). Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol, 69, 2989-97.
19. Kantola S, Parikka M, Jokinen K, et al (2000). Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer, 83, 614-9.
20. Karlsen F, Kalantari M, Jenkins A, et al (1996). Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol, 34, 2095-100.
21. Kies MS, Ang KK, Clayman GL (2009). Cancer of the Oropharynx. Cancers of the Head and Neck, Myers EN SJ, Myers JN, Hanna, EYN, Elsevier: 322.
22. Kim SC, Suh SP, Kee SJ, et al (1997). Detection of human papillomavirus in uterine cervical cancer tissues by polymerase chain reaction, In Situ hybridization and polymerase chain reaction In Situ techniques. Korean J Clin Pathol, 17, 287-95.
23. Klaes R, Friedrich T, Spitkovsky D, et al (2001). Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer, 92, 276-84.
24. Koskinen WJ, Chen RW, Leivo I, et al (2003). Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer, 107, 401-6.
25. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev, 14, 467-75.
26. Licitra L, Perrone F, Bossi P, et al (2006). High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol, 24, 5630-6.
27. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM, (2001). Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer, 92, 805-13.
28. Liselotte D, Hanna MD, David L, et al (2004). Human Papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer, 112, 1015-9.
29. Lo KW, Cheung TH, Chung TK, et al (2001). Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers. Gynecol Obstet Invest, 51, 202-7.
30. Macfarlane GJ, Boyle P, Scully C (1987). Rising mortality from cancer of the tongue in young Scottish males. Lancet, 2, 912.
31. May KMC, Lau KM, Tsui Y, et al (1996). Human papillomavirus infection in Hong Kong Chinese women with normal and abnormal cervix- detection by polymerase chain reaction method on cervical scrapes. Gynecol Oncol, 60, 217-23.
32. McKaig RG, Baric, RS, Olshan AF (1998). Human papillomavirus and head and neck cancer:epidemiology and molecular biology. John Wiley & Sons, Inc: 250-265.
33. Mellin H, Friesland S, Lewensohn R, Dalianis T, Ewa M-W (2000). Human papillomavirus(HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer, 89, 300-304.
34. Noureen MC, Chaturvedi P (2009). Role of human papilloma virus in the oral carcinogenesis: An Indian perspective. J Cancer Res Ther, 5, 71-7.
35. Pilch H, Günzel S, Schäffer U, et al (2001). The presence of HPV DNA in cervical cancer: Correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer, 11, 39-48.
36. Pillai MR, Phanidhara A, Kesari AL, Nair P, Nair MK (1999). Cellular manifestations of human papillomavirus infection in the oral mucosa. J Surg Oncol, 71, 10-5.
37. Pim D, Collins M, Banks L (1992). Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene, 7, 27-32.
38. Sanger F, Nicklen S, Coulson AR (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA, 74, 5463-7.
39. Schwarz E, Freese UK, Gissmann L, et al (1985), Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature, 314, 111-4.
40. Schwartz SM, Daling JR, Doody DR, et al (1998). Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst, 90, 1626-36.
41. Shiboski CH, Schmidt BL, Jordan RC (2005). Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer, 103, 1843-9.
42. Smith EM, Ritchie JM, Summersgill KF, et al (2004). Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst, 96, 449-55.
43. Strome SE, Savva A, Brissett AE, et al (2002). Squamous cell carcinoma of the tonsils: A molecular analysis of HPV associations. Clin Cancer Res, 8, 1093-100.
44. Syrjänen S (2004). HPV infection in tonsillar carcinoma. J Clin Pathol, 57, 449-55.
45. Talora C, Sgroi DC, Crum CP, Dotto GP (2002). Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev, 16, 2252-63.
46. Tezal M, Sullivan MA, Reid ME, et al (2007). Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg, 133, 450-454.
47. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX (2002). Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene, 21, 1510-7.
48. Wilczynski SP, Lin BT, Xie Y, Paz IB (1998). Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol, 152, 145-6.
49. Xin-Hua Liang JL, Foote R, Smith D, Kademani D (2008). Prevalence and significance of human papillomavirus in oral tongue cancer:The Mayo Clinic Experience. J Oral Maxillofac Surg, 66, 1875-1880.
50. Zur Hausen H, (1996). Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta, 1288, F55-78.